Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
Identifieur interne : 000542 ( Main/Exploration ); précédent : 000541; suivant : 000543Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
Auteurs : Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]Source :
- CNS drugs [ 1179-1934 ] ; 2015.
English descriptors
- KwdEn :
- Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Dopamine Agonists (adverse effects), Dopamine Agonists (therapeutic use), Ergot Alkaloids (adverse effects), Ergot Alkaloids (therapeutic use), Heart Failure (chemically induced), Heart Failure (epidemiology), Heart Valve Diseases (chemically induced), Heart Valve Diseases (epidemiology), Humans, Observational Studies as Topic, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Risk.
- MESH :
- chemical , adverse effects : Antiparkinson Agents, Dopamine Agonists, Ergot Alkaloids.
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Ergot Alkaloids.
- chemically induced : Heart Failure, Heart Valve Diseases.
- drug therapy : Parkinson Disease.
- epidemiology : Heart Failure, Heart Valve Diseases, Parkinson Disease.
- Humans, Observational Studies as Topic, Risk.
Abstract
Dopamine agonists (DAs) are commonly used in the therapy of Parkinson's disease (PD). However, several observational studies have suggested a putative association between DAs and specific cardiac adverse events.
DOI: 10.1007/s40263-015-0293-4
PubMed: 26585874
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000359
- to stream PubMed, to step Curation: 000359
- to stream PubMed, to step Checkpoint: 000359
- to stream Ncbi, to step Merge: 001D83
- to stream Ncbi, to step Curation: 001D83
- to stream Ncbi, to step Checkpoint: 001D83
- to stream Main, to step Merge: 000543
- to stream Main, to step Curation: 000542
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.</title><author><name sortKey="Tran, Tanja" sort="Tran, Tanja" uniqKey="Tran T" first="Tanja" last="Tran">Tanja Tran</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Brophy, James M" sort="Brophy, James M" uniqKey="Brophy J" first="James M" last="Brophy">James M. Brophy</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Renoux, Christel" sort="Renoux, Christel" uniqKey="Renoux C" first="Christel" last="Renoux">Christel Renoux</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada. christel.renoux@mcgill.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26585874</idno><idno type="pmid">26585874</idno><idno type="doi">10.1007/s40263-015-0293-4</idno><idno type="wicri:Area/PubMed/Corpus">000359</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000359</idno><idno type="wicri:Area/PubMed/Curation">000359</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000359</idno><idno type="wicri:Area/PubMed/Checkpoint">000359</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000359</idno><idno type="wicri:Area/Ncbi/Merge">001D83</idno><idno type="wicri:Area/Ncbi/Curation">001D83</idno><idno type="wicri:Area/Ncbi/Checkpoint">001D83</idno><idno type="wicri:Area/Main/Merge">000543</idno><idno type="wicri:Area/Main/Curation">000542</idno><idno type="wicri:Area/Main/Exploration">000542</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.</title><author><name sortKey="Tran, Tanja" sort="Tran, Tanja" uniqKey="Tran T" first="Tanja" last="Tran">Tanja Tran</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Brophy, James M" sort="Brophy, James M" uniqKey="Brophy J" first="James M" last="Brophy">James M. Brophy</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author><author><name sortKey="Renoux, Christel" sort="Renoux, Christel" uniqKey="Renoux C" first="Christel" last="Renoux">Christel Renoux</name><affiliation wicri:level="4"><nlm:affiliation>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec, Canada. christel.renoux@mcgill.ca.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, Quebec</wicri:regionArea><orgName type="university">Université McGill</orgName><placeName><settlement type="city">Montréal</settlement><region type="state">Québec</region></placeName></affiliation></author></analytic><series><title level="j">CNS drugs</title><idno type="eISSN">1179-1934</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Dopamine Agonists (adverse effects)</term><term>Dopamine Agonists (therapeutic use)</term><term>Ergot Alkaloids (adverse effects)</term><term>Ergot Alkaloids (therapeutic use)</term><term>Heart Failure (chemically induced)</term><term>Heart Failure (epidemiology)</term><term>Heart Valve Diseases (chemically induced)</term><term>Heart Valve Diseases (epidemiology)</term><term>Humans</term><term>Observational Studies as Topic</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (epidemiology)</term><term>Risk</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agonists</term><term>Ergot Alkaloids</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Dopamine Agonists</term><term>Ergot Alkaloids</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Heart Failure</term><term>Heart Valve Diseases</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Heart Failure</term><term>Heart Valve Diseases</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Observational Studies as Topic</term><term>Risk</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dopamine agonists (DAs) are commonly used in the therapy of Parkinson's disease (PD). However, several observational studies have suggested a putative association between DAs and specific cardiac adverse events.</div></front></TEI><affiliations><list><country><li>Canada</li></country><region><li>Québec</li></region><settlement><li>Montréal</li></settlement><orgName><li>Université McGill</li></orgName></list><tree><country name="Canada"><region name="Québec"><name sortKey="Tran, Tanja" sort="Tran, Tanja" uniqKey="Tran T" first="Tanja" last="Tran">Tanja Tran</name></region><name sortKey="Brophy, James M" sort="Brophy, James M" uniqKey="Brophy J" first="James M" last="Brophy">James M. Brophy</name><name sortKey="Renoux, Christel" sort="Renoux, Christel" uniqKey="Renoux C" first="Christel" last="Renoux">Christel Renoux</name><name sortKey="Suissa, Samy" sort="Suissa, Samy" uniqKey="Suissa S" first="Samy" last="Suissa">Samy Suissa</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000542 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000542 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26585874
|texte= Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26585874" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |